Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-25-291733·Repare Therapeutics Inc.
Schedule 13D ownership disclosure
REPARE THERAPEUTICS INC
Common Shares · CUSIP: 760273102
Event date: 2025-11-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Versant Venture Capital V, L.P.Reported CIK 0001589097
Shares: 0 · Class: 0.0%
- Versant Affiliates Fund V, L.P.Reported CIK 0001589095
Shares: 2,693 · Class: 0.0%
- Versant Ophthalmic Affiliates I, L.P.Reported CIK 0001589098
Shares: 2,982 · Class: 0.0%
- Versant Ventures V, LLCReported CIK 0001619298
Shares: 5,675 · Class: 0.0%
- Versant Venture Capital V (Canada) LPReported CIK 0001612235
Shares: 6,814 · Class: 0.0%
- Versant Ventures V (Canada), L.P.Reported CIK 0001716490
Shares: 6,814 · Class: 0.0%
- Versant Ventures V GP-GP (Canada), Inc.Reported CIK 0001619297
Shares: 6,814 · Class: 0.0%
- Versant Venture Capital VI, L.P.Reported CIK 0001687880
Shares: 0 · Class: 0.0%
- Versant Ventures VI GP, L.P.Reported CIK 0001777654
Shares: 0 · Class: 0.0%
- Versant Ventures VI GP-GP, LLCReported CIK 0001777652
Shares: 0 · Class: 0.0%
- Versant Vantage I, L.P.Reported CIK 0001765253
Shares: 72,211 · Class: 0.2%
- Versant Vantage I GP, L.P.Reported CIK 0001777651
Shares: 72,211 · Class: 0.2%
- Versant Vantage I GP-GP, LLCReported CIK 0001777653
Shares: 72,211 · Class: 0.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-291733
- Form type
- SCHEDULE 13D/A
- Filer
- Repare Therapeutics Inc.
- CIK
- CIK 1808158
- Filed
- Nov 21, 2025
- Reporting period
- Nov 19, 2025
- Description
- Schedule 13D beneficial ownership